Cardinal Health Accounts Receivable, Credit Loss Expense (Reversal) increased by 8.3% to $13.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 18.8%, from $16.00M to $13.00M. Over 2 years (FY 2021 to FY 2025), Accounts Receivable, Credit Loss Expense (Reversal) shows a downward trend with a -9.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may signal deteriorating customer credit health or a more aggressive sales strategy targeting riskier clients.
This represents the estimated expense for accounts receivable that the company believes will not be collected. It serves...
Standard metric for any business extending credit terms to customers.
operating_provision_for_doubtful_accounts| Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.00M | $12.00M | $47.00M | $29.00M | $58.00M | $9.00M | $19.00M | $0.00 | $8.00M | $16.00M | $11.00M | $14.00M | $12.00M | $13.00M |
| QoQ Change | — | -25.0% | +291.7% | -38.3% | +100.0% | -84.5% | +111.1% | -100.0% | — | +100.0% | -31.3% | +27.3% | -14.3% | +8.3% |
| YoY Change | — | — | — | +141.7% | — | -69.0% | — | -100.0% | — | +77.8% | -42.1% | — | +50.0% | -18.8% |